Shares of Vertex Pharmaceuticals Inc. VRTX slid 0.46% to $408.76 Friday, on what proved to be an all-around rough trading ...

This was the stock's fourth consecutive day of gains.

NEW YORK, NY / ACCESSWIRE / December 26, 2024 / Levi & Korsinsky notifies investors that it has commenced an investigation of Vertex ...

Vertex Pharmaceuticals Inc (VRTX) stock saw a modest uptick, ending the day at $408.18 which represents a slight increase of $2.91 or 0.72% from the prior close of $405.27. The stock opened at $401.53 ...

We recently compiled a list of the 10 Stocks That Will Make You Rich In 2025. In this article, we are going to take a look at ...

Vertex Pharmaceuticals Incorporated today announced that Dr. Reshma Kewalramani, Chief Executive Officer and President, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Monday, ...

Analysts have been eager to weigh in on the Healthcare sector with new ratings on BioNTech SE (BNTX – Research Report), Vertex Pharmaceuticals ...

Moon Surgical, a pioneer in laparoscopic surgical innovation, today announced the appointment of Chris Toth as an independent member of its Board of Directors. With over 20 years of experience in ...

Bruce Cozadd, who co-founded the company two decades ago, will step down once a successor is found. Jazz aims to complete its ...

BERWYN, PA – Virpax Pharmaceuticals Inc. (NASDAQ:VRPX), a micro-cap pharmaceutical company with a market capitalization of $2.07 million, reported today the immediate resignation of Mr. Gary Herman ...

Charlie Hall is Polygon’s tabletop editor. In 10-plus years as a journalist & photographer, he has covered simulation, strategy, and spacefaring games, as well as public policy. Hearts of Iron ...

to its Board of Directors. Dr. Hughes brings extensive experience from his leadership roles at major biopharmaceutical companies, including Vertex Pharmaceuticals and Novartis. Monte Rosa's CEO ...